Manufacturer or GPO Program year 2025 Source: CMS Open Payments

Astellas Pharma Europe Ltd

Great Britain (UK)

CMS manufacturer 100001449427

Open in the dashboard

General payments

$930,436

366 payments

Research payments

$0

0 payments

Ownership & investment interest

$0

None reported

Through program year 2025, Astellas Pharma Europe Ltd reported paying $930,436 in general payments and $0 in research payments to U.S. physicians, teaching hospitals and other recipients.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2025 General $407,276 199
2024 General $523,161 167

Breakdown

Top recipients General payments · program year 2025
  1. Stephen Freedland Urology · West Hollywood, CA $89,760 30 payments
  2. Joaquin Bellmunt Molins Medical Oncology · Boston, MA $52,349 6 payments
  3. Teri Longacre Anatomic Pathology & Clinical Pathology · Stanford, CA $38,759 2 payments
  4. Andrew Armstrong Medical Oncology · Durham, NC $33,984 13 payments
  5. Risa Kagan Obstetrics & Gynecology · Berkeley, CA $28,904 22 payments
  6. Vadim Koshkin Internal Medicine · Cleveland, OH $28,211 20 payments
  7. Shilpa Gupta Hematology & Oncology · Minneapolis, MN $24,129 16 payments
  8. Daniel Petrylak Medical Oncology · New Haven, CT $18,441 23 payments
  9. Kristina Matkowskyj Clinical Pathology/Laboratory Medicine · Rochester, MN $16,961 5 payments
  10. Raghav Sundar Medical Oncology · New Haven, CT $16,385 10 payments
Products the payments named General payments · program year 2025
  1. Xtandi Oncology $123,744 30% · 2 recipients
  2. Padcev Oncology $120,827 30% · 6 recipients
  3. Vyloy Oncology $116,064 28% · 24 recipients
  4. Veozah Biological $32,104 8% · 2 recipients
  5. Izervay Ophthalmology $8,448 2% · 4 recipients

The top 5 of 6 products; each share is of this company’s general payments naming a product in 2025. A payment can name up to five products, so these amounts overlap.

The top 25 products, free in the app

Specialties paid General payments · program year 2025
  1. Medical Oncology Internal Medicine $148,080 36% · 15 practitioners
  2. Urology $89,760 22% · 1 practitioner
  3. Anatomic Pathology & Clinical Pathology Pathology $38,759 10% · 1 practitioner
  4. Hematology & Oncology Internal Medicine $33,798 8% · 6 practitioners
  5. Obstetrics & Gynecology $32,104 8% · 2 practitioners

The top 5 of 10 specialties; each share is of this company’s general payments to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. California $168,316 41% · 7 recipients
  2. Massachusetts $52,428 13% · 2 recipients
  3. Connecticut $45,781 11% · 3 recipients
  4. Minnesota $41,090 10% · 2 recipients
  5. North Carolina $34,062 8% · 2 recipients

The top 5 of 17 states; each share is of this company’s general payments in 2025 where a state was reported.

The top 25 states, free in the app

What the payments were for General payments · program years 2024–2025
  1. Consulting Fee $560,290 83 payments
  2. Travel and Lodging $352,933 150 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $12,793 3 payments
  4. Food and Beverage $4,420 130 payments
Companies with a similar name General payments · program years 2024–2025
  1. Astellas Pharma US Inc IL, United States $46,786,131
  2. Astellas Pharma Global Development IL, United States $3,060,688
  3. Astellas Pharma Inc Japan $1,539,962
  4. Astellas US LLC IL, United States $17,220
  5. Astellas Pharma Europe BV Netherlands $14,536
  6. Astellas US Technologies IL, United States $0

Grouped by name only. CMS publishes no corporate ownership, so a shared name does not mean a shared parent.

366 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers of drugs, devices and biologicals, and group purchasing organisations, are required to report the payments and transfers of value they make to physicians and teaching hospitals. This page shows what this company reported.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record